Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP3 | O14638 | 3/20 | 0.65 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.65 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.62 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.62 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 3/20 | 0.49 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.49 |
| ▸ | BAX | Q07812 | 1/20 | 0.49 |
| ▸ | SMO | Q99835 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.45 |
| ▸ | USP7 | Q93009 | 1/20 | 0.45 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5836271 | 0.85 | ENPP3 (0.89) | ENPP3ENPP1HSD17B1HSD17B2MMP13 | |
| SCHEMBL5836277 | 0.83 | MMP13 (0.52) | ENPP3ENPP1HSD17B1HSD17B2MMP13 | |
| SCHEMBL5836726 | 0.82 | MMP13 (0.55) | ENPP3ENPP1HSD17B1HSD17B2MMP13 | |
| SCHEMBL3271684 | 0.82 | ENPP3 (0.72) | ENPP3ENPP1HSD17B1HSD17B2MMP13 | |
| SCHEMBL11566150 | 0.82 | ENPP3 (0.72) | ENPP3ENPP1HSD17B1HSD17B2MMP13 | |
| SCHEMBL5836684 | 0.81 | MMP13 (0.58) | ENPP3ENPP1HSD17B1HSD17B2MMP13 | |
| SCHEMBL5664564 | 0.81 | ENPP3 (0.75) | ENPP3ENPP1HSD17B1HSD17B2MMP13 | |
| Benzene SCHEMBL16781371 | 0.80 | ENPP3 (0.69) | ENPP3ENPP1HSD17B1HSD17B2SMO | |
| SCHEMBL278182 | 0.80 | ENPP3 (0.69) | ENPP3ENPP1HSD17B1HSD17B2SMO | |
| SCHEMBL5836215 | 0.79 | MMP13 (0.57) | ENPP3ENPP1HSD17B1HSD17B2MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7119201-B2 | Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors | PFIZER INC (US) | 2006-10-10 | — | — | US | disclosed |
| EP-1501515-B1 | TRIARYL-OXY-ARYLOXY-PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS | PFIZER PROD INC (US) | 2005-11-02 | — | — | EP | disclosed |
| US-20040006057-A1 | Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors | PFIZER PRODUCTS INC. | 2004-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006057-A1 | Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors | MMP8, MMP9, MMP1 | ENPP3 378/4885ENPP1 130/4885HSD17B1 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.